RIO DE JANEIRO, BRAZIL - The tightening of the U.S. blockade policy against Cuba is affecting national drug production in the Caribbean nation, Tania Urquiza, vice president of the BioCubaFarma business group, said Tuesday.
"The unilateral policy of the United States toward the island has led to a financial siege of the island nation as well as the refusal of a group of shipping companies to cooperate with Cuba," the official said at a press conference at the headquarters of AICA Laboratories on the outskirts of Havana.
Urquiza pointed out that the U.S. blockade restricts Cuba's access to . . .